Compounds > omega-n-methylarginine
Page last updated: 2024-09-03

omega-n-methylarginine and angiotensin ii, des-phe(8)-

omega-n-methylarginine has been researched along with angiotensin ii, des-phe(8)- in 1 studies

Compound Research Comparison

Studies
(omega-n-methylarginine)		Trials
(omega-n-methylarginine)		Recent Studies (post-2010)
(omega-n-methylarginine)		Studies
(angiotensin ii, des-phe(8)-)		Trials
(angiotensin ii, des-phe(8)-)		Recent Studies (post-2010) (angiotensin ii, des-phe(8)-)
4,4113443361,53321995

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brosnihan, KB; Ishii, M; Masumori-Maemoto, S; Ueda, S; Umemura, S; Wada, A1

Trials

1 trial(s) available for omega-n-methylarginine and angiotensin ii, des-phe(8)-

ArticleYear
Angiotensin(1-7) potentiates bradykinin-induced vasodilatation in man.
    Journal of hypertension, 2001, Volume: 19, Issue:11

    Topics: Adult; Angiotensin I; Angiotensin II; Bradykinin; Cross-Over Studies; Double-Blind Method; Drug Synergism; Enzyme Inhibitors; Humans; Male; omega-N-Methylarginine; Peptide Fragments; Reference Values; Vasoconstrictor Agents; Vasodilation

2001